GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qilian International Holding Group Ltd (NAS:QLI) » Definitions » Operating Cash Flow per Share

Qilian International Holding Group (Qilian International Holding Group) Operating Cash Flow per Share : $0.01 (TTM As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Qilian International Holding Group Operating Cash Flow per Share?

Qilian International Holding Group's operating cash flow per share for the six months ended in Sep. 2023 was $0.02. Qilian International Holding Group's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.01.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Qilian International Holding Group was -97.50% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -60.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Qilian International Holding Group's Operating Cash Flow per Share or its related term are showing as below:

QLI' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -60.4   Med: -57.1   Max: 23.5
Current: -60.4

During the past 7 years, Qilian International Holding Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 23.50% per year. The lowest was -60.40% per year. And the median was -57.10% per year.

QLI's 3-Year OCF Growth Rate is ranked worse than
96.41% of 807 companies
in the Drug Manufacturers industry
Industry Median: 8.2 vs QLI: -60.40

Qilian International Holding Group Operating Cash Flow per Share Historical Data

The historical data trend for Qilian International Holding Group's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qilian International Holding Group Operating Cash Flow per Share Chart

Qilian International Holding Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Operating Cash Flow per Share
Get a 7-Day Free Trial -0.02 0.15 0.01 0.35 0.01

Qilian International Holding Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.26 0.12 0.24 -0.01 0.02

Competitive Comparison of Qilian International Holding Group's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Qilian International Holding Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qilian International Holding Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Qilian International Holding Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Qilian International Holding Group's Price-to-Operating-Cash-Flow falls into.



Qilian International Holding Group Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Qilian International Holding Group's Operating Cash Flow per Share for the fiscal year that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (A: Sep. 2023 )=Cash Flow from Operations (A: Sep. 2023 )/Shares Outstanding (Diluted Average) (A: Sep. 2023 )
=0.312/35.750
=0.01

Qilian International Holding Group's Operating Cash Flow per Share for the quarter that ended in Sep. 2023 is calculated as

Operating Cash Flow per Share (Q: Sep. 2023 )=Cash Flow from Operations (Q: Sep. 2023 )/Shares Outstanding (Diluted Average) (Q: Sep. 2023 )
=0.761/35.750
=0.02

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qilian International Holding Group Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Qilian International Holding Group's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Qilian International Holding Group (Qilian International Holding Group) Business Description

Traded in Other Exchanges
N/A
Address
Jiuquan Economic and Technological Development Zone, Gansu Province, Jiuquan, CHN, 735000
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.

Qilian International Holding Group (Qilian International Holding Group) Headlines

From GuruFocus